Marshall Wace
PRAH

Marshall Wace’s PRA Health Sciences, Inc. PRAH Stock Holding History

Marshall Wace’s Portfolio PRAH Stock Details PRAH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-134,119
Closed -$22.2M – 3676
2021
Q2 		$22.2M Sell
134,119
-2,979
-2% -$497K 0.1% 210
2021
Q1 		$21M Buy
+137,098
New +$18.6M 0.1% 206
2020
Q2 		– Sell
-7,556
Closed -$627K – 2097
2020
Q1 		$627K Sell
7,556
-97,610
-93% -$9.52M 0.01% 922
2019
Q4 		$11.7M Buy
105,166
+39,613
+60% +$4.07M 0.08% 289
2019
Q3 		$6.5M Sell
65,553
-206,827
-76% -$20.5M 0.05% 423
2019
Q2 		$27M Buy
272,380
+181,867
+201% +$17.4M 0.22% 94
2019
Q1 		$9.98M Buy
90,513
+78,499
+653% +$8.2M 0.09% 261
2018
Q4 		$1.1M Sell
12,014
-40,632
-77% -$4.11M 0.01% 890
2018
Q3 		$5.8M Buy
+52,646
New +$5.48M 0.05% 428
2018
Q1 		– Sell
-78,160
Closed -$7.12M – 673
2017
Q4 		$7.12M Buy
78,160
+66,971
+599% +$5.57M 0.3% 72
2017
Q3 		$850K Buy
+11,189
New +$846K 0.04% 239
2017
Q2 		– Sell
-17,927
Closed -$1.17M – 405
2017
Q1 		$1.17M Sell
17,927
-1,238,174
-99% -$72.9M 0.06% 196
2016
Q4 		$69.2M Buy
1,256,101
+401,341
+47% +$22M 0.46% 47
2016
Q3 		$48.3M Sell
854,760
-45,233
-5% -$2.22M 0.34% 75
2016
Q2 		$37.6M Sell
899,993
-2,252
-0.2% -$104K 0.32% 74
2016
Q1 		$38.6M Buy
902,245
+655,624
+266% +$27.7M 0.37% 71
2015
Q4 		$11.2M Sell
246,621
-8,677
-3% -$365K 0.1% 205
2015
Q3 		$9.91M Buy
255,298
+3,923
+2% +$157K 0.12% 180
2015
Q2 		$9.13M Buy
251,375
+22,104
+10% +$699K 0.12% 190
2015
Q1 		$6.61M Hold
229,271
– – 0.09% 261
2014
Q4 		$5.55M Buy
+229,271
New +$5.17M 0.07% 289

Other funds holding PRAH

BCI
Brinker Capital Investments Berwyn, Pennsylvania $11.7B AUM 21.33% 1-Year Est. Return

Marshall Wace's PRAH Position: Q3 2021 in Review

Marshall Wace sold out of PRA Health Sciences, Inc. (PRAH) in Q3 2021, closing a stake of 134,119 shares — an estimated $22.2M sold.

Marshall Wace first reported a position in PRAH in Q4 2014 and held it in 21 quarters. The position peaked at $69.2M in Q4 2016. 1 fund tracked by Wall St. Rank holds PRAH as of Q3 2021.

  • Marshall Wace reported no remaining PRA Health Sciences, Inc. position as of Q3 2021 after selling out during the quarter.
  • Marshall Wace sold 134,119 PRA Health Sciences, Inc. shares in Q3 2021, an estimated $22.2M.
  • Marshall Wace first reported a position in PRA Health Sciences, Inc. in Q4 2014 and held it in 21 quarters.
  • Marshall Wace's PRA Health Sciences, Inc. position peaked at $69.2M in Q4 2016.
  • 1 fund tracked by Wall St. Rank held PRA Health Sciences, Inc. as of Q3 2021.

Based on Marshall Wace's 13F filing for Q3 2021, filed 15 Nov 2021.